BDMD Baird Medical Investment Holdings Ltd

$0.14 -10.32%

Data as of Nov 2, 2026 close

Healthcare · Surgical & Medical Instruments & Apparatus

Baird Medical Investment Holdings Ltd (BDMD) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $6 million. Shares last traded at $0.14, 96.2% below their 52-week high. Over the past year the stock is down 90.9%. Net profit margin is -121.0%, below the peer median of -6.9%. Revenue declined 39.2% year over year.

Market Cap

$6M

Shares Out

41.0M

EPS (TTM)

-$0.98

P/E (TTM)*

—

P/S Ratio

0.25

P/B Ratio

0.18

Dividend / Share

—

Dividend Yield

—

52-Week High

$3.68

52-Week Low

$0.07

Volume (venue)

1.8M

Avg Vol (3m, venue)

32,270.302

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

-67.27%

-81.78%

-87.59%

-92.01%

YTD

-89.82%

-90.86%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

16.14

SMA (50)

$0.79

SMA (200)

$1.34

Price vs SMA50

-82.51%

Price vs SMA200

-89.62%

ATR (14)

$0.08

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$23M

Net Income

-$27M

Gross Margin

83.8%

Operating Margin

-113.7%

Net Margin

-121.0%

Return on Equity

-87.0%

Return on Assets

-39.1%

Current Ratio

1.70

Debt / Equity

0.28

Revenue Growth (YoY)

-39.2%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2025-12-31. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Surgical & Medical Instruments & Apparatus peers

BDMD vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Data as of Nov 2, 2026 close

P/S vs peers

0.25 / 2.81 med

-91% discount

Net margin vs peers

-121.0% / -6.9% med

below median

1–14 of 14


SYK	Stryker Corporation	$116.8B	32.25	4.44	13.8%	+5.32%
MMM	3M	$92.2B	26.07	3.65	14.0%	+2.35%
BSX	Boston Scientific	$64.3B	18.39	3.05	16.6%	+5.62%
BDX	Becton Dickinson	$54.1B	57.49	2.60	4.5%	+0.39%
RMD	ResMed	$32.8B	20.56	5.71	27.8%	+1.35%
DXCM	DexCom	$31.6B	31.90	6.19	19.4%	+2.99%
MDLN	Medline Inc.	$29.5B	—	1.04	—	+4.80%
WST	West Pharmaceutical Services	$28.4B	44.46	8.36	18.8%	-1.15%
SOLV	Solventum	$14.4B	10.06	1.74	17.3%	+4.22%
GKOS	Glaukos Corp	$14.1B	—	20.48	-24.6%	+0.53%
PEN	Penumbra Inc	$12.7B	80.67	9.02	11.2%	+0.42%
BAX	Baxter International	$12.5B	—	1.08	-6.2%	+5.47%
GMED	Globus Medical Inc	$10.7B	19.92	3.39	17.0%	+1.81%
PODD	Insulet Corporation	$10.7B	28.39	3.49	12.3%	+2.58%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.